ConductScience.org, home

Gene · 84959

UBASH3B: ubiquitin associated and SH3 domain containing B

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. UBASH3B: ubiquitin associated and SH3 domain containing B. Genes, record 84959. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/84959

On this page

Gene

Symbol
UBASH3B
HGNC
Name
ubiquitin associated and SH3 domain containing B
HGNC
NCBI Gene ID
84959
NCBI Gene
HGNC ID
HGNC:29884
HGNC
Ensembl
ENSG00000154127
NCBI Gene
Aliases
KIAA1959, STS-1, STS1, TULA-2, TULA2, p70
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q8TF42Ubiquitin-associated and SH3 domain-containing protein B6496Ensembl, GeneID, HGNC

Source UniProt

Patents21

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1468872Q8TF42Espacenet
JP 2025032204 A2025-03-1137934Q8TF42Espacenet
EP 4461818 A22024-11-1337934Q8TF42Espacenet
JP 2023058610 A2023-04-2537934Q8TF42Espacenet
US 11446398 B22022-09-2094515Q8TF42Espacenet
JP 2022524081 A2022-04-27197486Q8TF42Espacenet
US 11078247 B22021-08-0312217Q8TF42Espacenet
WO 2020239947 A12020-12-0387Q8TF42Espacenet
JP 2020508652 A2020-03-2637934Q8TF42Espacenet
JP 2019054813 A2019-04-11249307Q8TF42Espacenet

1 to 10 of 21

See all 21 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants1,414

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleUBASH3B papersNewest fiscal year
P30CA008748Cancer Center Support Grant92025
P30CA016672Cancer Center Support Grant92025
P30CA036727Buffett Cancer Center Support Grant52025
P30CA010815Consolidated Basic Cancer Research Program42025
P30CA014195Cancer Center Support Grant (CCSG)42025
P30CA021765Cancer Center Support Grant (CCSG)42025
P30EY001792P30 Core Grant for Vision Research42025
R01HL095524Modulation of Lung Disease by Genetic/Epigenetic Profiling42025
P30CA016520Abramson Cancer Center Support Grant32025
P30CA023108Cancer Center Support Grant32025

1 to 10 of 1,414Source NIH's project files

See all 1,414 nih grants

Papers1,799

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Interleukin-12: Central Roles in Immune Regulation and Disease Therapy.Immunol Cell Biol202642813654PubTator, text miningPubMed
Hypoxia drives ferroptosis resistance and immunosuppression in hepatocellular carcinoma by inducing UBASH3B-mediated glutamine metabolism reprogramming and CXCL8 expression.Redox Biol202642594485PubTator, text miningPubMed
TASP1-mediated cleavage of REV3L enhances the activity of DNA polymerase ζ in mammalian cells.Nat Commun202642297787PubTator, text miningPubMed
Sit-to-stand test as a complementary assessment in patients with cardiovascular disease.Rev Cuid202642282077PubTator, text miningPubMed
SR-B1 knockdown suppresses breast cancer cell proliferation, migration, and invasion via the PI3K/AKT pathway.Einstein (Sao Paulo)202642154876PubTator, text miningPubMed
ADAR2 induces the differentiation of osteosarcoma cells by editing activity on IGFBP7: new implications for therapy.Bone Res202641927527PubTator, text miningPubMed
The role of disulfidptosis-driven tumor microenvironment remodeling in pancreatic cancer progression.Front Immunol202641884834PubTator, text miningPubMed
Eco-enhanced silicone rubber composites reinforced with micro and nano iron slag and TiO₂ for thermal stability and radiation protection.Sci Rep202641760718PubTator, text miningPubMed
AUM-302, a novel triple PIM/PI3K/mTOR inhibitor, synergizes with RAS inhibition and impedes the growth of pancreatic ductal adenocarcinoma spheroids and organoids.Front Pharmacol202641756246PubTator, text miningPubMed
Rational Design, Synthesis, and Molecular Docking of Novel Terpene Analogues of Imatinib, and Their Inhibition on Downstream BCR-ABL Signaling.Pharmaceuticals (Basel)202641754740PubTator, text miningPubMed

1 to 10 of 1,799

See all 1,799 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/84959

GET https://conductscience.org/api/genes/v1/84959/patents?page=2